New Alzheimer’s Drug Arrives in India: Can It Really Slow Memory Decline?
According to top doctors, not all dementia patients would benefit. "Donanemab is best suited for early symptomatic Alzheimer’s disease, mild cognitive impairment due to Alzheimer’s, mild Alzheimer’s dementia, Amyloid-positive patients…